Yixin Xu | Cardiovascular Researches | Best Researcher Award 2025

Published on by Cardiology and Cardiovascular Medicine

Dr. Yixin Xu | Cardiovascular Researches | Best Researcher Award

The First Affiliated Hospital of Army Medical University | China

Author Profile

Orcid

Early Academic Pursuits

YiXin Xu began her medical journey at Xinjiang Medical University, where she pursued an undergraduate degree in Clinical Medicine. Her strong academic performance and dedication to patient care inspired her to continue postgraduate studies in Internal Medicine, specializing in cardiovascular medicine. This early pursuit of advanced knowledge built the foundation for her growing expertise in both clinical practice and research.

Professional Endeavors

Her professional development included an internship at the Traditional Chinese Medicine Hospital of Shapingba District in Chongqing City, where she gained valuable clinical exposure. She then undertook standardized resident physician training at the First Affiliated Hospital of Xinjiang Medical University. During this period, she successfully managed patient care, independently handled on-duty responsibilities, and developed expertise in treating conditions such as coronary heart disease, hypertension, and pulmonary hypertension.

Contributions And Research Focus

She has contributed to several important research projects that bridge clinical practice with scientific inquiry. These include investigating the relationship between vitamin D, parathyroid hormone, and circadian rhythms in blood pressure regulation among patients with hypertension. She also participated in the Step-Pre Project and the "iCare-Me" initiative, both of which aim to improve patient outcomes through innovative approaches. Additionally, she contributed to the creation of a predictive model for heart failure in patients with coronary heart disease, based on metabolic biomarkers, highlighting her focus on precision medicine and translational research.

Clinical Expertise

Through her training, she became proficient in both the theoretical and practical aspects of internal medicine. She is skilled in the standardized documentation of medical records, surgical notes, and disease course records. Her technical expertise includes performing essential clinical procedures such as abdominal puncture and bone marrow puncture. These abilities underscore her readiness to practice medicine at a high professional standard.

Impact And Influence

Her dual contributions as a clinician and researcher have positioned her to influence both patient care and the scientific community. By combining clinical experience with data-driven research, she advances understanding in cardiovascular disease while improving strategies for patient management. Her work reflects a commitment to bridging the gap between medical research and real-world healthcare delivery.

Academic Cites

Her scholarly contributions have been acknowledged through participation in collaborative studies and cited within ongoing cardiovascular research initiatives. These academic references reflect her growing influence and recognition within the medical research community.

Legacy And Future Contributions

Looking forward, she aspires to strengthen predictive models for cardiovascular disease and enhance evidence-based treatment protocols. Her career vision includes contributing to global medical research networks, publishing impactful studies, and advancing patient care practices through innovation and collaboration.

Conclusion

YiXin Xu exemplifies the qualities of a dedicated physician and researcher. With her academic excellence, clinical expertise, and meaningful research contributions, she is poised to make significant advancements in cardiovascular medicine. Her commitment to innovation and patient-centered care ensures that she will leave a lasting impact on both clinical practice and medical science.

Notable Publication

"Parathyroid hormone and vitamin D modulate nocturnal blood pressure dipping: a retrospective cohort study in primary hypertension"

Authors: Yixin Xu, Changjiang Deng, Xiaohui Liang
Journal: Clinical and Experimental Hypertension
Year: 2025

Bo Yang | Cardiovascular Disease | Best Researcher Award 2025

Published on by Cardiology and Cardiovascular Medicine

Prof. Bo Yang | Cardiovascular Disease | Best Researcher Award

Wenzhou Medical University | China

Author Profile

Scopus

Google Scholar 

Early Academic Pursuits

Dr. Bo Yang began his academic journey with a strong foundation in the field of nutrition and health sciences. He pursued his doctoral degree at Zhejiang University through a collaborative international research program with Harvard University. This early exposure to global academic environments enabled him to acquire a multidisciplinary perspective and laid the groundwork for his career in nutritional science and lipid medicine. His academic training emphasized both molecular-level investigation and broader public health perspectives, bridging basic research with applied health outcomes.

Professional Endeavors

Following his doctoral studies, Dr. Yang expanded his expertise through postdoctoral training at China Medical University in Taiwan. These experiences enriched his understanding of advanced methodologies in nutrition and health research. He later joined Wenzhou Medical University, where he currently serves as a Research Professor and Director of the Institute of Lipids Medicine. In this leadership role, Dr. Yang oversees both research and academic development, guiding projects that integrate basic, clinical, and translational research approaches.

Contributions And Research Focus

Dr. Yang’s research centers on nutritional epidemiology, functional lipids, and health management. His work explores the role of lipid metabolism and bioactive compounds in mind-body health, with a special emphasis on how dietary interventions influence chronic disease prevention. By integrating molecular nutrition with population-based approaches, his research addresses pressing public health challenges while providing evidence for precision nutrition strategies. His expertise spans functional lipids, mind-body health, and diet-related interventions, making significant contributions to the field of nutritional sciences.

Impact And Influence

With an extensive body of published work in peer-reviewed scientific journals, Dr. Yang has established himself as a recognized voice in the field of nutrition and lipid research. His contributions include more than fifty publications in SCI-indexed journals. Beyond his own research, he actively serves as a peer reviewer for prestigious journals such as Brain, Behavior & Immunity, Food & Function, and Nutrients. His editorial role as Statistical Editor for the British Journal of Nutrition further demonstrates his influence in shaping scientific communication and ensuring methodological rigor in nutrition science.

Academic Cites

Dr. Yang’s publications have been widely cited by scholars and researchers across the globe. His contributions to nutritional epidemiology and lipid metabolism have provided reference points for emerging research in functional foods, mind-body health, and chronic disease prevention. By bridging laboratory findings with population-based studies, his work is frequently referenced in both clinical nutrition and public health research, enhancing the academic discourse in these fields.

Legacy And Future Contributions

Dr. Yang’s legacy lies in his integration of molecular nutrition with population-based health studies, offering a holistic approach to understanding the role of diet in human health. His leadership at the Institute of Lipids Medicine positions him to continue fostering innovation in nutritional research and health management. Future contributions are expected to expand into precision nutrition, functional food development, and preventive strategies for chronic diseases, influencing both academic research and public health policy.

Conclusion

Dr. Bo Yang exemplifies the qualities of an accomplished researcher and academic leader in nutritional science and lipid medicine. His career demonstrates a commitment to advancing scientific knowledge, mentoring future scholars, and addressing global health challenges through nutrition-focused solutions. With his proven track record of impactful research, editorial leadership, and international collaboration, Dr. Yang is poised to make enduring contributions to the fields of nutrition, health, and medicine.

Notable Publications

"Effect of Clostridium butyricum against Microglia‐Mediated Neuroinflammation in Alzheimer's Disease via Regulating Gut Microbiota and Metabolites Butyrate"

Authors: Jing Sun, Jingxuan Xu, Bo Yang, Keyang Chen, Yu Kong, Na Fang, Tianyu Gong, Fangyan Wang, Zongxin Ling, Jiaming Liu
Journal: Molecular nutrition & food research
Year: 2020

"Effects of low-fat compared with high-fat diet on cardiometabolic indicators in people with overweight and obesity without overt metabolic disturbance: a systematic review and meta-analysis of randomised controlled trials"

Authors: Mengqing Lu, Yi Wan, Bo Yang, Catherine E Huggins, Duo Li
Journal: British Journal of Nutrition
Year: 2018

"Effects of vegetarian diets on blood lipids: a systematic review and meta‐analysis of randomized controlled trials"

Authors: Fenglei Wang, Jusheng Zheng, Bo Yang, Jiajing Jiang, Yuanqing Fu, Duo Li
Journal: Journal of the American Heart Association
Year: 2015

"Ratio of n-3/n-6 PUFAs and risk of breast cancer: a meta-analysis of 274135 adult females from 11 independent prospective studies"

Authors: Bo Yang, Xiao-Li Ren, Yuan-Qin Fu, Jin-Long Gao, Duo Li
Journal: BMC cancer
Year: 2014

 

Dani Qin | Cardiovascular Disease | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Dani Qin | Cardiovascular Disease | Best Researcher Award

Yixing People's Hospital | China

Author Profiles

Scopus

Orcid

Early Academic Pursuits

Qin Dani began her academic journey with a strong foundation in pediatrics, completing her studies at a prestigious medical university and further pursuing advanced training. Her dedication to continuous learning is evident as she continues doctoral studies at a reputed university. Her academic background laid the groundwork for her clinical expertise and research orientation in pediatric healthcare.

Professional Endeavors

She has established herself as a key figure in the Department of Pediatrics at Yixing People's Hospital, where she has been contributing her expertise for many years. During her career, she also pursued advanced studies and training at well-regarded medical institutions, which broadened her clinical skills and enriched her professional development. She currently holds a leadership role as an Associate Chief Physician and plays an active part in pediatric development teams, shaping the direction of child healthcare services.

Contributions and Research Focus

Her clinical work spans the diagnosis and treatment of a wide spectrum of pediatric conditions, with particular strengths in infant and toddler health care, respiratory disorders, digestive system diseases, and neonatal health management. She has led several important research projects at provincial and municipal levels, demonstrating her commitment to bridging clinical practice with academic research. Her published works reflect a dedication to advancing pediatric medicine through evidence-based studies and practical insights.

Impact and Influence

Through her leadership and expertise, she has significantly contributed to improving pediatric care standards in her community and beyond. Her ability to manage both common and critical pediatric illnesses has earned her recognition among colleagues and institutions alike. Her influence extends to mentoring young professionals, thereby fostering the next generation of pediatric specialists.

Academic Cites

She has authored numerous academic publications in both international and national journals, with multiple contributions recognized in core and indexed platforms. Her scholarly work has been acknowledged through prestigious awards in natural science and academic excellence, showcasing her impact in both scientific and clinical communities.

Legacy and Future Contribution

Her career trajectory reflects a deep commitment to pediatric medicine, both in clinical practice and academic advancement. With her ongoing doctoral research, she is expected to make further strides in pediatric healthcare innovations. Her legacy will likely continue through her contributions to research, her role in nurturing young professionals, and her influence on public health standards in pediatrics.

Recognition and Honors

She has received several commendations from healthcare authorities and academic institutions for her outstanding contributions, including recognition for advanced individual achievements and excellence in academic publications. These accolades highlight her dedication, professionalism, and long-term impact in the medical field.

Conclusion

Qin Dani exemplifies the qualities of an accomplished physician, researcher, and academic leader. Her blend of clinical expertise, research achievements, and commitment to advancing pediatric medicine has left a lasting mark on both medical practice and scientific scholarship. With a proven record of excellence and continued pursuit of innovation, she stands as a role model in the field of pediatrics, poised to make even greater contributions in the years ahead.

Notable Publications

"Methionine sulfoxide suppresses adipogenic differentiation by regulating the mitogen‐activated protein kinase signaling pathway"

Authors: Dani Qin; Yong Lei; Wen Xie; Qiuju Zheng; Zhou Peng; Yiwen Liu; Biao Dai; Tieliang Ma; Ping
Journal: Cell Biology
Year: 2023

"Effects of miR-19b Overexpression on Proliferation, Differentiation, Apoptosis and Wnt/β-Catenin Signaling Pathway in P19 Cell Model of Cardiac Differentiation In Vitro"

Authors: Da-Ni Qin; Lingmei Qian; De-Liang Hu; Zhang-Bin Yu; Shu-Ping Han; Chun Zhu; Xuejie Wang;
Journal: Cell Biochemistry and Biophysics
Year: 2013

Christina Antza | Hypertension | Best Research Article Award

Published on by Cardiology and Cardiovascular Medicine

Assist. Prof. Dr. Christina Antza | Hypertension | Best Research Article Award

Assist. Prof. Dr. Christina Antza, 3rd Department of Internal Medicine, Aristotle University of Thessaloniki, Greece

Assist. Prof. Dr. Christina Antza is a specialist in Internal Medicine and Hypertension at the 3rd Department of Internal Medicine, Aristotle University of Thessaloniki, Greece. She holds an M.D., a Ph.D. in blood pressure measurement methods, and an M.Sc. in Research Methodology. Dr. Antza has extensive experience in hypertension, metabolic syndrome, diabetes, and atherosclerosis. She has worked as a researcher, consultant, and medical educator in Greece and the UK. Recognized with multiple awards and fellowships, she actively contributes to international medical research and education, shaping advancements in cardiovascular and metabolic disease management.

AUTHOR PROFILE

Orcid Profile

🎓 EARLY ACADEMIC PURSUITS:

Dr. Christina Antza began her educational journey at the Fifth High-School of Drama (Junior High School) and Third High School of Drama (Senior High School). She then pursued her Medical Degree at Aristotle University of Thessaloniki, Greece (2007-2013), graduating with an impressive 8/10 grade.

Her passion for research and academia led her to further studies, including:

  • Ph.D. in Internal Medicine (2014-2019) – Focused on blood pressure measurement methods and their ability to predict early vascular aging. She earned a Grade A with Distinction under the supervision of Prof. V. Kotsis.
  • Master of Science in Research Methodology in Medicine and Health Science (2016-2018) – Achieved an outstanding 9/10 grade.
  • Research Fellowship (2019-2020) – Conducted clinical and research work in Diabetes Mellitus and Obesity at the University of Birmingham, UK.
  • Postdoctoral Research (2019-2022) – Specialized in Hypertension and Metabolic Syndrome at Aristotle University of Thessaloniki.
  • Internal Medicine Consultant Certification (2021) – Earned after passing rigorous written and oral examinations.

💼 PROFESSIONAL ENDEAVORS:

Dr. Antza has held various prestigious roles in internal medicine, focusing on hypertension, metabolic syndrome, and endocrinology:

  • Scientific Associate (2013-2014) – Engaged in research and clinical practice in hypertension at the 3rd Department of Internal Medicine, Aristotle University of Thessaloniki.
  • Medical Resident (2016-2021) – Trained at Papageorgiou General Hospital, Aristotle University of Thessaloniki.
  • Academic Fellowship in Hypertension & Metabolic Syndrome (2021-2022) – Focused on clinical practice, independent teaching, and research.
  • Internal Medicine Consultant (2021-2023) – Served at Papageorgiou General Hospital and Bioclinic, offering expertise in hypertension, diabetes, and emergency medicine.
  • Assistant Professor of Internal Medicine – Hypertension (2023-Present) – Currently educating future medical professionals and leading research at Aristotle University of Thessaloniki.

Additionally, she has participated as a Subinvestigator in Phase 2 & 3 Clinical Trials, contributing to advancements in hypertension and metabolic disorders.

📚 CONTRIBUTIONS AND RESEARCH FOCUS ON HYPERTENSION:

Dr. Antza has extensively researched hypertension, metabolic syndrome, diabetes, lipid disorders, and vascular aging. Her work has focused on:

  • Blood Pressure Measurement Techniques (Home, Ambulatory, and Clinical).
  • Atherosclerosis and Cardiovascular Risk.
  • Metabolic Syndrome and Obesity-Related Disorders.
  • Diabetes and Endocrine Disorders.

She has been actively involved in research collaborations with leading medical institutions, including Queen Elizabeth Hospital, Birmingham, UK, where she served as an Honorary Observer (2019-2022) in the Endocrinology Department.

🏆 IMPACT AND INFLUENCE:

Dr. Antza’s work has been recognized with numerous awards and fellowships:

  • Young Fellow of the European Atherosclerosis Society (2019-Present).
  • Young Fellow of the European Hypertension Society (2023-Present).
  • Recipient of multiple Investigator Grants & Travel Awards from the European Society of Hypertension (ESH) and European Atherosclerosis Society (EAS).
  • 1st Place Oral Presentation Award – 8th Panhellenic Congress of the Hellenic Atherosclerosis Society (2019).
  • 2nd Clinical Research Award – 9th Panhellenic Congress of the Hellenic Atherosclerosis Society (2020).
  • Young Investigator Fellowship Award – 89th EAS Virtual Congress (2021).

📖 ACADEMIC CITATIONS & SCHOLARSHIPS:

Dr. Antza’s research has been widely cited in medical literature, influencing clinical guidelines in hypertension and metabolic diseases. Her scholarly excellence has earned her:

  • Ph.D. Scholarship from the Hellenic Society of Atherosclerosis (2014-2015).
  • Postdoctoral Research Scholarship from the State Scholarship Foundation (2019-2021).
  • Award from the Medical Sciences Deanery for Ph.D. Research (2020).

🌍 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Christina Antza is poised to make significant future contributions in the diagnosis and management of hypertension, metabolic syndrome, and cardiovascular diseases. Her expertise in clinical research, education, and innovative treatment strategies will continue to shape internal medicine and patient care.

Her future goals include:
✔ Expanding research on hypertension-related complications and vascular aging.
✔ Leading international collaborations in cardiovascular and metabolic diseases.
✔ Mentoring the next generation of medical professionals and researchers.
✔ Contributing to global guidelines on hypertension and cardiovascular risk management.

Her dedication to patient care, research, and teaching makes her an influential figure in modern internal medicine and hypertension research.

🌟CONCLUSION :

Assist. Prof. Dr. Christina Antza is a dedicated clinician, researcher, and educator in the fields of hypertension, metabolic syndrome, and internal medicine. With a strong academic foundation, international research collaborations, and numerous accolades, she continues to advance medical knowledge and improve patient care. Her contributions to medical education and research have made a lasting impact, inspiring future generations of physicians. As she progresses in her career, Dr. Antza remains committed to innovation, scientific discovery, and excellence in healthcare, shaping the future of cardiovascular and metabolic disease management. Her work stands as a testament to dedication and expertise.

TOP NOTABLE PUBLICATIONS

Clinic, Ambulatory and Home Blood Pressure Monitoring for Metabolic Syndrome: Time to Change the Definition?

Journal: Medicina

Year: 2025

The Microbial Perspective: A Systematic Literature Review on Hypertension and Gut Microbiota

Journal: Nutrients

Year: 2024

The Effects of Olive Oil Consumption on Biochemical Parameters and Body Mass Index of People with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Journal: Nutrients

Year: 2024

Familial Hypercholesterolemia in the Elderly: An Analysis of Clinical Profile and Atherosclerotic Cardiovascular Disease Burden from the Hellas-FH Registry

Journal: Biomedicines

Year: 2024

The Modern Environment: The New Secondary Cause of Hypertension?

Journal: Medicina

Year: 2023

The Importance of Out-of-Office Blood Pressure Measurement, as Highlighted by the Correlation with Left Ventricular Hypertrophy in an Untreated Hypertensive Population

Journal: Medicina

Year: 2023

Zhihui Zhang | Cardiovascular Research | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Zhihui Zhang | Cardiovascular Research | Best Researcher Award

Prof. Zhihui Zhang, Army Medical University, China

Prof. Zhihui Zhang is a distinguished researcher at Army Medical University, China, specializing in cardiovascular diseases and stem cell therapy. His work focuses on endothelial seed cells, myocardial infarction, and immunosuppressive capabilities of mesenchymal stem cell-derived extracellular vesicles. He has published extensively in leading journals such as Genes and Diseases, Science Bulletin, and Stem Cell Research and Therapy. Prof. Zhang’s research contributes to advancing early diagnosis and targeted interventions for coronary microvascular dysfunction. His expertise in molecular biology and regenerative medicine has made significant impacts in cardiovascular research and clinical applications.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Zhihui Zhang embarked on his academic journey with a deep passion for cardiovascular medicine. His early education laid a strong foundation in medical sciences, leading him to specialize in cardiology. His dedication and excellence in research and clinical practice positioned him for advanced studies and significant contributions to the field.

🏥PROFESSIONAL ENDEAVORS:

Dr. Zhang is the Director of the Department of Cardiology at the First Affiliated Hospital (Southwest Hospital) of the Army Medical University in Chongqing. His leadership extends beyond the hospital as he holds multiple prestigious roles:

  • Member of the Great Vessel Group under the Cardiology Branch of the Chinese Medical Association
  • Member of the Cardiologists’ Association of the Chinese Medical Doctor Association
  • Deputy Director of the Committee for Structural Heart Disease under the China Human Health Promotion Association
  • Deputy Director of the Cardiology Branch of the Chongqing Medical Association, leading the Interventional Cardiology and Imaging Group

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR RESEARCH:

Dr. Zhang is renowned for his expertise in interventional treatment of coronary heart disease and structural heart disease. His research focuses on:

  • Precise diagnosis and treatment of coronary heart disease
  • Interventional therapy for valvular heart diseases
  • Establishing a cohort for precise classification of myocardial ischemia
  • Creating a biobank and an artificial intelligence center for coronary angiography physiological assessment

Additionally, he has developed the professional Circa Met DB database, specializing in metabolic circadian rhythms.

🌍IMPACT AND INFLUENCE:

Dr. Zhang’s contributions have earned him numerous accolades, including:
🏆 Two first prizes for scientific progress in Chongqing
🏆 One first prize for scientific progress in Hubei Province
🏆 One second prize for military medical achievements

He has successfully led over 20 research projects, ranging from national natural science funds to key military and Chongqing talent programs. His pioneering work in cardiology has influenced national and military healthcare policies.

📖ACADEMIC CITATIONS:

Dr. Zhang has an outstanding publication record, with more than 30 SCI papers as the first or corresponding author (including co-first/co-corresponding). His research has been featured in top-tier journals such as:
📌 The Lancet
📌 Nature Metabolism
📌 Nature Communications
📌 Trends in Cell Biology

Additionally, he has contributed to drafting and setting 12 expert consensus documents, served as a deputy editor for two monographs, and contributed to nine other books. His work extends to two national invention patents, further solidifying his impact in the field.

🚀LEGACY AND FUTURE CONTRIBUTIONS:

As a recipient of the Outstanding Youth Talent Fund in National Defense Bioscience, Dr. Zhang is recognized as a key innovator in cardiology. He has been honored as an Innovation Leading Talent by the Chongqing Talents Program and as a Science and Technology Talent by the Army.

His legacy will continue to shape the future of cardiovascular medicine through:
✅ Advanced research in interventional cardiology
✅ Expansion of AI-driven medical diagnostics
✅ Development of groundbreaking therapeutic techniques
✅ Mentorship and training of future cardiologists

🌟CONCLUSION:

Prof. Zhihui Zhang is a visionary leader in cardiology, blending clinical excellence, groundbreaking research, and technological innovation. His contributions have not only transformed patient care but also advanced global medical knowledge. His work will undoubtedly influence generations of medical professionals and redefine the future of cardiovascular treatment.

TOP NOTABLE PUBLICATIONS

Single nucleotide polymorphisms: Implications in the early diagnosis and targeted intervention of coronary microvascular dysfunction

Authors: Dingyuan Tian, Jie Li, Qingyuan Yang, Zhihui Zhang, Fang Deng

Journal: Genes and Diseases

Year: 2025

Circadian nutrition: is meal timing an elixir for fatigue?

Authors: Zhihui Zhang, Lu Yan, Jonas T. Treebak, Min-Dian Li

Journal: Science Bulletin

Year: 2025

Foxo1 drives the TGFβ1-dependent dichotomy of Th17 cell fates

Authors: Mengjuan Zhang, Yude Guan, Meijuan Han, Xiaomin Zhang, Song Zhang

Journal: Journal of Leukocyte Biology

Year: 2025

The short-term outcomes and risk factors of post-myocardial infarction ventricular septal rupture: a multi-center retrospective study

Authors: Wenjian Luo, Li Wen, Jinning Zhang, Zhexue Qin, Shiyong Yu

Journal: Journal of Cardiothoracic Surgery

Year: 2024

Sources and applications of endothelial seed cells: a review

Authors: Dan Deng, Yu Zhang, Bo Tang, Zhihui Zhang

Journal: Stem Cell Research and Therapy

Year: 2024

Enhanced immunosuppressive capability of mesenchymal stem cell-derived small extracellular vesicles with high expression of CD73 in experimental autoimmune uveitis

Authors: Yanan Duan, Xiteng Chen, Hui Shao, Jiawei Wang, Xiaomin Zhang

Journal: Stem Cell Research and Therapy

Year: 2024

Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression

Authors: Junjie Tang, Yaoming Liu, Yinghao Wang, Ping Zhang, Rong Lu

Journal: Biomarker Research

Year: 2024

Associations between non-insulin-based insulin resistance indices and heart failure prevalence in overweight/obesity adults without diabetes mellitus: evidence from the NHANES 2001–2018

Authors: Diyu Cui, Chao Zhang, Yi Chen, Yu Zhang, Ping Zhu

Journal: Lipids in Health and Disease

Year: 2024

Single-cell transcriptomics enable the characterization of local extension in retinoblastoma

Authors: Yaoming Liu, Wei Hu, Yanjie Xie, Shengli Li, Rong Lu

Journal: Communications Biology

Year: 2024

Clinical characteristics of patients with moderate or severe valvular heart disease

Authors: Hao Gao, Yuzhu Lei, Haiyun Huang, Yanxiu Chen, Zhihui Zhang

Journal: Chinese Journal of Cardiology

Year: 2024

Dandan Tian | Hypertension | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Dandan Tian | Hypertension | Best Researcher Award

Dr.  Dandan Tian, Henan Provincial People’s Hospital, China

Dr. Dandan Tian is a medical professional at Henan Provincial People’s Hospital in China. With a focus on clinical practice, her expertise spans a variety of medical specialties, particularly in patient care and hospital management. Dr. Tian has made significant contributions to advancing healthcare in the region through her dedication to improving medical services and patient outcomes. She is well-regarded for her professional approach, collaboration with medical teams, and commitment to providing high-quality healthcare. Dr. Tian’s work has also involved research and development aimed at enhancing medical practices and addressing regional healthcare challenges.

Author Profile

Scopus Profile

EARLY ACADEMIC PURSUITS:

Dr. Dandan Tian’s academic journey laid a solid foundation for her distinguished career in hypertension prevention and treatment. After completing her formal medical education, she focused her studies on cardiovascular diseases, particularly hypertension, which has remained a central theme throughout her career. Her commitment to medical research, along with her clinical training, enabled her to understand the complexities of hypertension, and she quickly became passionate about improving treatment protocols and preventative care measures. Early on, her academic curiosity and dedication positioned her to contribute significantly to the growing body of knowledge in her field.

PROFESSIONAL ENDEAVORS:

Dr. Tian currently serves as the Attending Physician in the Hypertension Department of Henan Provincial People’s Hospital. This prestigious role allows her to apply her expertise in diagnosing and treating hypertension while maintaining a hands-on approach with patient care. Beyond her clinical responsibilities, Dr. Tian has taken on significant leadership roles, including Secretary of the Hypertension Prevention and Treatment Center of Henan Province and Secretary of the Hypertension Targeted Center Alliance. Her professional endeavors emphasize collaboration and innovation, as she continues to be a key player in hypertension care across the region.

CONTRIBUTIONS AND RESEARCH FOCUS ON HYPERTENSION:

Dr. Tian’s research focus has been on advancing hypertension prevention, treatment, and management through evidence-based practices. She has made substantial contributions to the field by leading one provincial-level research project and participating in multiple national-level research efforts. These research projects aim to enhance the clinical understanding of hypertension, explore new treatment methods, and implement effective prevention strategies. Her involvement in ministerial and provincial-level research further highlights her commitment to improving public health and addressing hypertension on a broader scale.

IMPACT AND INFLUENCE:

Dr. Tian’s impact extends beyond her clinical and research work. Her leadership in the Hypertension Prevention and Treatment Center of Henan Province and her membership in key medical societies, including the Henan Microcirculation Society, have solidified her influence in the medical community. Additionally, she plays a vital role in shaping healthcare policy and practice, particularly regarding hypertension management and prevention. Dr. Tian was recognized as an exemplary individual in disease prevention and control work by the province in 2021, reflecting the widespread acknowledgment of her contributions to public health.

ACADEMIC CITES AND RECOGNITION:

Dr. Tian’s research has garnered significant academic recognition, with citations from peers and professionals in the field of hypertension and cardiovascular health. Her work on hypertension prevention and treatment protocols has been widely cited, contributing to the academic discourse on hypertension management both within China and internationally. This recognition serves as a testament to the relevance and impact of her research in improving hypertension care practices.

LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Tian’s legacy is shaped by her pioneering work in hypertension prevention and her dedication to improving patient outcomes. Her research and clinical expertise continue to inspire future generations of healthcare professionals and researchers. Moving forward, Dr. Tian’s contributions are expected to pave the way for further advancements in hypertension management, particularly with her ongoing leadership in various professional committees and research projects. She is committed to continuing her work in hypertension treatment and prevention, and her future contributions are likely to have an enduring impact on the field.

CONCLUSION:

Dr. Dandan Tian’s career reflects a deep commitment to both the clinical and academic sides of hypertension management. Her early academic pursuits, professional endeavors, and continued contributions to research have established her as a leader in the field. Through her work, she has influenced both healthcare policy and patient care practices. With a lasting impact on hypertension prevention, Dr. Tian is poised to continue making significant contributions to the field, solidifying her place as a leading figure in cardiovascular health.

TOP NOTABLE PUBLICATIONS

Article: Effects of obesity on aging brain and cognitive decline: A cohort study from the UK Biobank

Authors: Li, P., Zhu, X., Huang, C., Su, J., Tian, D.

Journal: IBRO Neuroscience Reports

Year: 2025

Article: Joint Exposure to Ambient Air Pollutants, Genetic Risk, and Ischemic Stroke: A Prospective Analysis in UK Biobank

Authors: Li, P., Wang, Y., Tian, D., Su, J., Wang, M.

Journal: Stroke

Year: 2024

Article: Analysis of clinical and biochemical characteristics and left ventricular hypertrophy in patients with indeterminate saline infusion test results

Authors: Qu, H., Zhao, J., Wang, L., Hao, Y., Liu, M.

Journal: Frontiers in Endocrinology

Year: 2024

Article: Causal factors of cardiovascular disease in end-stage renal disease with maintenance hemodialysis: a longitudinal and Mendelian randomization study

Authors: Tian, D., Xu, Y., Wang, Y., Li, P., Li, X.

Journal: Frontiers in Cardiovascular Medicine

Year: 2024

Article: Association Between Plasma Levels of ANGPTL3, 4, 8 and the Most Common Additional Cardiovascular Risk Factors in Patients with Hypertension

Authors: Xu, F., Shen, L., Yang, Y., Cao, X., Huang, G.

Journal: Diabetes, Metabolic Syndrome and Obesity

Year: 2023

Article: Analysis of the Expression and Prognostic Potential of a Novel Metabolic Regulator ANGPTL8/Betatrophin in Human Cancers

Authors: Xu, F., Tian, D., Shi, X., Sun, K., Chen, Y.

Journal: Pathology and Oncology Research

Year: 2021

Article: Highly sensitive and selective photoelectrochemical sensor for mercury(II) detection based on efficient Bi2MoO6 photoanode decorated with CuS

Authors: Zhang, X., Li, M., He, L., Zhang, J., Liu, M.

Journal: Journal of Alloys and Compounds

Year: 2021

Article: ANGPTL8/betatrophin improves glucose tolerance in older mice and metabolomic analysis reveals its role in insulin resistance in HepG2 cells

Authors: Xu, F., Wang, N., Li, G., Tian, D., Shi, X.

Journal: Diabetes, Metabolic Syndrome and Obesity

Year: 2021

Article: Modeling analysis of the relationship between atherosclerosis and related inflammatory factors

Authors: Li, H., Zhang, P., Yuan, S., Tian, D., Liu, M.

Journal: Saudi Journal of Biological Sciences

Year: 2017

Jihong Hu | Hypertension | Best Researcher Award 

Published on by Cardiology and Cardiovascular Medicine

🎓Current Position and Research Focus:

Dr. Hu holds a position at a respected institution where they continue to contribute significantly to the fields of preventive medicine and public health. Their ongoing research focuses on areas such as hypertension, cardiovascular risk assessment, and traditional Chinese medicine applications for chronic disease prevention. Through innovative studies and applied clinical work, Dr. Hu aims to enhance understanding of disease mechanisms and contribute to the development of preventive strategies in both Western and traditional Chinese medicine.

📚Academic Background:

Dr. Hu began their academic journey at Ningxia Medical University, earning a master’s degree in preventive medicine in 2000. Subsequently, they completed an undergraduate degree in the same field, graduating in 2003. Driven by a passion for epidemiology and health statistics, Dr. Hu went on to earn a doctorate from Peking Union Medical College in 2007. These degrees laid a solid foundation for a career devoted to advancing preventive medicine in both academic and clinical settings.

📝Publications and Scientific Achievements:

Over the last five years, Dr. Hu has contributed numerous papers to prestigious journals, often as the first author or corresponding author. Notable publications include research on:

  • Salt sensitivity and hypertension, investigating how salt substitutes impact blood pressure across different age groups.
  • PD-L1 expression in colorectal cancer, where Dr. Hu’s analysis provided insights into prognostic factors.
  • Gut microbiome research, exploring its association with diseases like obesity and hypertension.

These publications highlight Dr. Hu's versatility in addressing a wide range of health issues, often using meta-analyses to consolidate knowledge across studies.

🔬Ongoing Research Projects:

Dr. Hu actively participates in numerous research projects, often funded by prestigious bodies like the National Natural Science Foundation of China. Current projects include:

  • Internet+Chinese Medicine Integration: Investigating the role of Chinese medicine in preventing and controlling chronic diseases through technology.
  • Pediatric Intestinal Microecology: Examining how gut health affects respiratory infections in children.
  • Lumbar Disc Herniation Therapy: Standardizing Chinese medicine treatments for lumbar issues, focusing on Gansu’s regional medical practices.
  • Stroke and Traditional Medicine: Studying ischemic stroke through a traditional Chinese medicine perspective and assessing its diagnostic value.

These projects underscore Dr. Hu’s dedication to combining traditional Chinese medicine with modern epidemiology, aiming to offer holistic health solutions.

🔍Research Interests:

Dr. Hu’s research interests cover an impressive range within public health and epidemiology. Key areas include:

  • Chronic disease management with a particular focus on hypertension and cardiovascular risk.
  • The role of environmental and epigenetic factors in disease, particularly cardiovascular disease.
  • Traditional Chinese medicine and its integration with modern public health strategies to combat chronic illnesses.

Dr. Hu's diverse research portfolio reflects a commitment to improving population health through innovative, cross-disciplinary approaches.

🏆Awards and Scholarships:

Throughout their career, Dr. Hu has received several awards and scholarships recognizing their contributions to public health and epidemiology. While specific awards were not mentioned, it's clear from their impressive body of work that they are a valued researcher in China’s medical community.

🎤Professional Associations and Presentations:

Dr. Hu is an active member of various professional associations within the fields of preventive medicine and public health. Dr. Hu has also delivered several oral presentations at conferences and academic forums, sharing insights from studies on hypertension, cardiovascular health, and public health interventions.

🎓Training & Workshops: 

To stay updated in their field, Dr. Hu participates in training programs and workshops, often centered around epidemiological methods and data analysis. These workshops have likely included training on statistical software, meta-analysis techniques, and advanced bioinformatics relevant to health research.

🧪Laboratory Experience and Success Factors: 

Dr. Hu has extensive experience in laboratory-based research, having worked on projects involving stem cell transplantation, cytokine analysis, and cardiovascular biomarkers. Success in this domain can be attributed to strong analytical skills, dedication, and the ability to apply multi-disciplinary methods to complex health issues.

🛠️Tasks Completed as a Researcher:

Dr. Hu’s responsibilities have included:

  • Conducting data collection and statistical analysis on health data.
  • Leading clinical trials on new treatments and interventions.
  • Collaborating with traditional Chinese medicine experts to develop integrated health strategies.
  • Supervising junior researchers and contributing to project planning.

These tasks demonstrate Dr. Hu’s role as a key contributor to both team-based research and individual projects.

Citations:

Citations  201

h-index  5

i10-index  4

🌍Conclusion: 

Dr. Jihong Hu’s career reflects a deep commitment to advancing preventive medicine and public health in China. Through ongoing projects, publications, and a dedication to both epidemiology and traditional medicine, Dr. Hu bridges ancient practices with modern science. Their work not only contributes to medical knowledge but also to improved health outcomes across populations. With a track record of impactful research and a forward-thinking approach, Dr. Hu continues to lead in the integrated field of preventive medicine and epidemiology.

Top Notable Publications:

Hu, J.-H., Wang, S.-X., Wang, Y., ... Wang, L., Zhang, J. (2024). Association between salt sensitivity of blood pressure and dietary habits in survey population: A case-control study. Clinical Nutrition ESPEN, 64, 229–235.

Jin, L., Fang, S., Nan, Y., Hu, J., Jin, H. (2024). The effect of air pollutants on COPD-hospitalized patients in Lanzhou, China (2015–2019). Frontiers in Public Health, 12, 1399662.

Wang, L., Hu, J. (2024). Unraveling the gut microbiota's role in salt-sensitive hypertension: current evidences and future directions. Frontiers in Cardiovascular Medicine, 11, 1410623.

Lei, R., Zhang, L., Liu, X., ... Ren, Z., Luo, B. (2024). Residential greenspace and blood lipids in an essential hypertension population: Mediation through PM2.5 and chemical constituents. Environmental Research, 240, 117418.

Xiao, Y., Liu, C., Lei, R., ... Hu, J., Luo, B. (2023). Associations of PM2.5 composition and green space with metabolic syndrome in a Chinese essential hypertensive population. Chemosphere, 343, 140243.

Wang, S., Hu, J., Dong, G., ... Chen, X., Ding, F. (2023). Effects of bone marrow cells transplantation for acute myocardial infarction on cardiac function, infarct size, and clinical events: A meta-analysis. Chinese Medical Journal, 136(20), 2518–2520.

Zhou, E., Lei, R., Tian, X., ... Luo, B., Hu, J. (2023). Association between salt sensitivity of blood pressure and the risk of hypertension in a Chinese Tibetan population. Journal of Clinical Hypertension, 25(5), 453–462.

Hu, J., Thompson, B., Wang, S., ... Cao, Z., Wang, J. (2022). Rate and risk factors of metabolic components and component combinations according to hypertension status in Tibetans in a cross-sectional study. Medicine (United States), 101(43), E31320.

Lei, R., Wang, Z., Wang, X., ... Zhang, K., Bin Luo (2022). Effects of long-term exposure to PM2.5 and chemical constituents on blood lipids in an essential hypertensive population: A multi-city study in China. Ecotoxicology and Environmental Safety, 242, 113867.

Li, M.-Y., Wang, S.-X., Liu, X.-B., ... Cao, J., Hu, J.-H. (2021). Comparative study on the mortality rate of children under 5 years old between China and Russia from 1990 to 2017. Zhongguo Ertong Baojian Zazhi, 29(9), 1021–1025.